Drug intelligence / Profile preview

si-KDM5B

Development stage
Preclinical
Lead developer
Dharmacon
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
In Vitro Transfection
01

Overview

si-KDM5B is a synthetic small interfering RNA (siRNA) molecule designed to specifically target and suppress expression of the lysine-specific demethylase 5B gene (KDM5B) via RNA interference. KDM5B is a histone demethylase that regulates chromatin structure and gene expression by removing methyl groups from H3K4me2/3 residues, thereby leading to transcriptional repression. si-KDM5B acts by binding to KDM5B mRNA, resulting in its degradation and decreased translation of the KDM5B protein. Knockdown of KDM5B using si-KDM5B increases H3K4 trimethylation, alters cell cycle dynamics, and has variable effects on cell proliferation and viability depending on cancer cell type and chemoresistance status. In sensitive neuroblastoma and hepatocellular carcinoma cell lines, si-KDM5B inhibits proliferation and tumorigenicity, arrests the cell cycle at the G1/S phase, and can increase sensitivity to chemotherapy. The molecule is primarily utilized as a research tool in functional genomics studies, often for mechanistic investigation and target validation rather than as an approved therapeutic.

Other names
short-interfering RNA targeting KDM5B
02

Targets

KDM5B (Lysine-specific demethylase 5B)

Beyond the preview

Go deeper on si-KDM5B.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on si-KDM5B.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call